Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by ScienceFirst


V.TLT

RE:RE:RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Thadeush ... You are correct.  Good observation.   Even NHL's...

August 23, 2023

V.TLT

RE:RE:RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Thanks for the clarification Eoganacht and EnriqueSuave. There's...

August 23, 2023

V.TLT

RE:Dr. Black article on Phase 2 Trial of Atezolizumab

Good observation DJDAWG about the market shaving 1B$US to IMMUNITYBIO (IBRX...

August 23, 2023

V.TLT

RE:Dr. Black article on Phase 2 Trial of Atezolizumab

At the time of the refusal in May, we learned that ImmunityBio had a big...

August 23, 2023

V.TLT

RE:Dr. Black article on Phase 2 Trial of Atezolizumab

DJDAWG ... Nice constructive post.  Thanks for providing the competition...

August 23, 2023

V.TLT

ImmunityBio swamped by class actions

IBRX (N-893 + BCG)  is swamped by class actions regarding the May 2023...

August 23, 2023

T.PYR

RE:RE:RE:RE:Funny

MollyRiley ... Good posts to debunk Tamarackflop. This guy has discredited...

August 23, 2023

T.PYR

RE:New job posting

One of these jobs is for plasma atomization.  So 3D-printing powder...

August 23, 2023

T.PYR

RE:New job posting

6 new jobs.   It must be because they have received some...

August 23, 2023

T.PYR

RE:What don't you get ?

Tamarackflop ... Your EXRO is down -30% since your February call of an "...

August 23, 2023

V.TLT

PhotoPharmacology conference end of Nov.

2nd participation of Prof. McFarland to this PhotoPharmacology conference. ...

August 22, 2023

T.PYR

RE:RE:PYR is flooded with FUDsters who claim they don't own shares

Tamarackflop ... "How is it so hard to wrap your head around the fact...

August 22, 2023

V.TLT

RE:FDA Breakthrough Therapy in 2023 …

  If a drug is designated as breakthrough therapy, FDA will expedite...

August 22, 2023

V.TLT

FDA Breakthrough Therapy in 2023 …

So far in 2023: https://www.fda.gov/media/97001/download Since...

August 22, 2023

T.PYR

RE:RE:RE:RE:RE:Summary of PYR business line development near term 0-3 mth

Tamarackflop posted daily that this company was done  over, no more...

August 22, 2023

V.HPQ

RE:RE:RE:RE:HPQ CEO interview Inside the Press Release

Pennymaker69 ... I don't think you understand how grants work.   ...

August 22, 2023

V.VPT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Ventripoint sells VMS+ to English children's hospital sells$

GrahamB ... I'm in PYR since 2016.  At 0.20$ and 0.30$.    ...

August 22, 2023

V.VPT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Ventripoint sells VMS+ to English children's hospital sells$

GrahamB ... You played FUD on the "no sale" issue when the stock...

August 22, 2023

T.PYR

RE:RE:RE:RE:Summary of PYR business line development near term 0-3 mth

GrahamB ... Speaking of insolvency, looks like you're not aware that...

August 22, 2023

T.PYR

RE:RE:RE:RE:RE:RE:RE:Working capital, ongoing losses

GrahamB ... You always downplay and discredit things by subtly omitting facts...

August 22, 2023

Featured Company